[1]荣幸,夏琍群.铁死亡在心血管疾病中的研究进展[J].国际心血管病杂志,2022,02:86-88,95.
点击复制
铁死亡在心血管疾病中的研究进展(PDF)
《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]
- 期数:
- 2022年02期
- 页码:
- 86-88,95
- 栏目:
- 综述
- 出版日期:
- 2022-06-01
文章信息/Info
- Title:
- -
- 作者:
- 荣幸; 夏琍群
- 铁死亡是由于二价铁过度累积、谷胱甘肽耗竭和脂质过氧化相互影响且级联 放大而导致的铁依赖性非凋亡性细胞坏死。铁死亡在心脏缺血再灌注损伤、阿霉素心肌病、 代谢性心肌病和心力衰竭等心血管疾病的发生发展中发挥着重要作用，有望成为心血管疾病 治疗的新靶点。
- Author(s):
- -
- 关键词:
- -
- Keywords:
- -
- 分类号:
- -
- DOI:
- 10.3969/j.issn.1673-6583.2022.02.007
- 文献标识码:
- -
- 摘要:
- 心力衰竭；缺血再灌注损伤；铁死亡；铁代谢
- Abstract:
- -
参考文献/References
[1] Del Re DP, Amgalan D, Linkermann A, et al. Fundamental
mechanisms of regulated cell death and implications for heart
disease[J]. Physiol Rev, 2019, 99(4):1765-1817.
[2] Galluzzi L, Vitale I, Aaronson SA, et al. Molecular
mechanisms of cell death: recommendations of the
Nomenclature Committee on Cell Death 2018[J]. Cell Death
Differ, 2018, 25(3):486-541.
[3] Bertrand RL. Iron accumulation, glutathione depletion,
and lipid peroxidation must occur simultaneously during
ferroptosis and are mutually amplifying events[J]. Med
Hypotheses, 2017, 101:69-74.
[4] Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an
iron-dependent form of nonapoptotic cell death[J]. Cell, 2012,
149(5):1060-1072.
[5] Stockwell BR, Friedmann Angeli JP, Bayir H, et al.
Ferroptosis: a regulated cell death nexus linking metabolism,
redox biology, and disease[J]. Cell, 2017, 171(2):273-285.
[6] Busti F, Marchi G, Ugolini S, et al. Anemia and iron deficiency
in cancer patients: role of iron replacement therapy[J].
Pharmaceuticals (Basel), 2018, 11(4):94.
[7] Hoes MF, Grote BN, Kijlstra JD, et al. Iron deficiency impairs
contractility of human cardiomyocytes through decreased
mitochondrial function[J]. Eur J Heart Fail, 2018, 20(5):910-
919.
[8] Baba Y, Higa JK, Shimada BK, et al. Protective effects of
the mechanistic target of rapamycin against excess iron and
ferroptosis in cardiomyocytes[J]. Am J Physiol Heart Circ
Physiol, 2018, 314(3):H659-H668.
[9] Zhang H, Zhabyeyev P, Wang S, et al. Role of iron metabolism
in heart failure: from iron deficiency to iron overload[J].
Biochim Biophys Acta Mol Basis Dis, 2019, 1865(7):1925-
1937.
[10] Sung HK, Song E, Jahng JWS, et al. Iron induces insulin
resistance in cardiomyocytes via regulation of oxidative
stress[J]. Sci Rep, 2019, 9(1):4668.
[11] Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion
injury: a neglected therapeutic target[J]. J Clin Invest, 2013,
123(1):92-100.
[12] Fang X, Wang H, Han D, et al. Ferroptosis as a target for
protection against cardiomyopathy[J]. Proc Natl Acad Sci U S
A, 2019, 116(7):2672-2680.
[13] Chang HC, Wu R, Shang M, et al. Reduction in mitochondrial
iron alleviates cardiac damage during injury[J]. EMBO Mol
Med, 2016, 8(3):247-267.
[14] Min SW, Chen X, Tracy TE, et al. Critical role of acetylation
in tau-mediated neurodegeneration and cognitive deficits[J].
Nat Med, 2015, 21(10):1154-1162.
[15] Park TJ, Park JH, Lee GS, et al. Quantitative proteomic
analyses reveal that GPX4 downregulation during myocardial
infarction contributes to ferroptosis in cardiomyocytes[J]. Cell
Death Dis, 2019, 10(11):835.
[16] Dabkowski ER, Williamson CL, Hollander JM. Mitochondriaspecific
transgenic overexpression of phospholipid
hydroperoxide glutathione peroxidase (GPx4) attenuates
ischemia/reperfusion-associated cardiac dysfunction[J]. Free
Radic Biol Med, 2008, 45(6):855-865.
[17] Feng Y, Madungwe NB, Imam AA, et al. Liproxstatin-1
protects the mouse myocardium against ischemia/reperfusion
injury by decreasing VDAC1 levels and restoring GPX4
levels[J]. Biochem Biophys Res Commun, 2019, 520(3):606-
611.
[18] Li W, Feng G, Gauthier JM, et al. Ferroptotic cell death and
TLR4/Trif signaling initiate neutrophil recruitment after heart
transplantation[J]. J Clin Invest, 2019, 129(6):2293-2304.
[19] Rupérez AI, Olza J, Gil-Campos M, et al. Association of
genetic polymorphisms for glutathione peroxidase genes with
obesity in Spanish children[J]. J Nutrigenet Nutrigenomics,
2014, 7(3):130-142.
[20] Katunga LA, Gudimella P, Efird JT, et al. Obesity in a
model of gpx4 haploinsufficiency uncovers a causal role
for lipid-derived aldehydes in human metabolic disease and
cardiomyopathy[J]. Mol Metab, 2015, 4(6):493-506.
[21] Baseler WA, Dabkowski ER, Jagannathan R, et al. Reversal
of mitochondrial proteomic loss in Type 1 diabetic heart with
overexpression of phospholipid hydroperoxide glutathione
peroxidase[J]. Am J Physiol Regul Integr Comp Physiol, 2013,
304(7):R553-R565.
[22] Behring JB, Kumar V, Whelan S, et al. Does reversible
cysteine oxidation link the Western diet to cardiac
dysfunction?[J]. FASEB J, 2014, 28(5):1975-1987.
[23] Chavez JD, Wu J, Bisson W, et al. Site-specific proteomic
analysis of lipoxidation adducts in cardiac mitochondria
reveals chemical diversity of 2-alkenal adduction[J]. J
Proteomics, 2011, 74(11):2417-2429.
[24] Huynh K, Kiriazis H, Du XJ, et al. Coenzyme Q10 attenuates
diastolic dysfunction, cardiomyocyte hypertrophy and cardiac
fibrosis in the db/db mouse model of type 2 diabetes[J].
Diabetologia, 2012, 55(5):1544-1553.
[25] Gu J, Cheng Y, Wu H, et al. Metallothionein is downstream
of Nrf2 and partially mediates sulforaphane prevention of
diabetic cardiomyopathy[J]. Diabetes, 2017, 66(2):529-542.
[26] Koleini N, Nickel BE, Edel AL, et al. Oxidized phospholipids
in Doxorubicin-induced cardiotoxicity[J]. Chem Biol Interact,
2019, 303:35-39.
[27] Wouters KA, Kremer LC, Miller TL, et al. Protecting
against anthracycline-induced myocardial damage: a review
of the most promising strategies[J]. Br J Haematol, 2005,
131(5):561-578.
[28] Tang M, Huang Z, Luo X, et al. Ferritinophagy activation
and sideroflexin1-dependent mitochondria iron overload is
involved in apelin-13-induced cardiomyocytes hypertrophy[J].
Free Radic Biol Med, 2019, 134:445-457.
[29] Fang X, Cai Z, Wang H, et al. Loss of cardiac ferritin H
facilitates cardiomyopathy via Slc7a11-mediated ferroptosis[J].
Circ Res, 2020, 127(4):486-501.
[30] Omiya S, Hikoso S, Imanishi Y, et al. Downregulation of
ferritin heavy chain increases labile iron pool, oxidative stress
and cell death in cardiomyocytes[J]. J Mol Cell Cardiol, 2009,
46(1):59-66.
[31] Chen X, Xu S, Zhao C, et al. Role of TLR4/NADPH oxidase 4
pathway in promoting cell death through autophagy and
ferroptosis during heart failure[J]. Biochem Biophys Res
Commun, 2019, 516(1):37-43.
[32] Ramu E, Korach A, Houminer E, et al. Dexrazoxane prevents
myocardial ischemia/reperfusion-induced oxidative stress in
the rat heart[J]. Cardiovasc Drugs Ther, 2006, 20(5):343-348.
[33] Miotto G, Rossetto M, Di Paolo ML, et al. Insight into the
mechanism of ferroptosis inhibition by ferrostatin-1[J]. Redox
Biol, 2020, 28:101328.
备注/Memo
- 备注/Memo:
-
作者单位：200092 上海交通大学医学院附属新华医院中医科
通信作者：夏琍群, E-mail: xialiqun@xinhuamed.com.cn
常用功能
统计/Statistics
- 摘要浏览/Viewed66
- 全文下载/Downloads392
- 评论/Comments
